Colon tumour cells increase PGE 2 by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation

Carcinogenesis

Volumn 32, Issue 11, 2011, Pages 1741-1747

  Roberts, Heather R ^a   Smartt, Helena J M ^a   Greenhough, Alexander ^a   Moore, Amy E ^a   Williams, Ann C ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE 2; GLUCOSE; PROSTAGLANDIN E2; SMALL INTERFERING RNA;

ARTICLE; CELL SURVIVAL; COLON CARCINOGENESIS; COLON TUMOR; ENVIRONMENTAL STRESS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

ANOXIA; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; ELAFIN; GLUCOSE; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR CHOP; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

EID: 80755168365     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr210     Document Type: Article

References (48)

1. Gatenby, R.A. et al. (2008) A microenvironmental model of carcinogenesis. Nat. Rev. Cancer, 8, 56-61.
2. Albini, A. et al. (2007) The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer, 7, 139-147.
3. Graeber,T.G. et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
4. Yun,J. et al. (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science, 325, 1555-1559.
5. 2 availability on human cancer. Nat. Rev. Cancer, 8, 967-975.
6. Stolina,M. et al. (2000) Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol., 164, 361-370.
7. 2 protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in ApcMin/+ mice. Cancer Res., 62, 403-408.
8. Eberhart,C.E. et al. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
9. Elder,D.J. et al. (2002) Human colorectal adenomas demonstrate a sizedependent increase in epithelial cyclooxygenase-2 expression. J. Pathol., 198, 428-434.
10. Δ" 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
11. Baron,J.A. et al. (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology, 131, 1674-1682.
12. Bertagnolli,M.M. et al. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N. Engl. J. Med., 355, 873-884.
13. 2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30, 377-386.
14. Myung,S.J. et al. (2006) 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc. Natl Acad. Sci. USA, 103, 12098-12102.
15. Wolf,I. et al. (2006) 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res., 66, 7818-7823.
16. Ding,Y. et al. (2005) NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Carcinogenesis, 26, 65-72.
17. Huang,G. et al. (2008) 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3b and a tumor suppressor in lung cancer. Cancer Res., 68, 5040-5048.
18. Kaidi,A. et al. (2006) Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res., 66, 6683-6691.
19. 2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis, 30, 1796-1804.
20. Williams,A.C. et al. (1990) Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res., 50, 4724-4730.
21. Paraskeva,C. et al. (1989) Specific cytogenetic abnormalities in two new human colorectal adenomaderived epithelial cell lines. Cancer Res., 49, 1282-1286.
22. Kaidi,A. et al. (2007) Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol., 9, 210-217.
23. Otto,J.C. et al. (1993) N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem., 268, 18234-18242.
24. 2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase. Mol. Pharmacol., 71, 1715-1720.
25. Thiel,A. et al. (2009) 15-hydroxyprostaglandin dehydrogenase is downregulated in gastric cancer. Clin. Cancer Res., 15, 4572-4580.
26. Chell,S.D. et al. (2006) Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res., 66, 3106-3113.
27. 2 signalling in colorectal adenoma cells. Oncogene, 29, 3398-3410.
28. Sheng,H. et al. (1998) Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem., 273, 22120-22127.
29. Sheng,H. et al. (2001) K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res., 61, 2670-2675.
30. St-Germain,M.-E. et al. (2004) Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB/IκB pathway. Mol. Cancer, 3, 7.
31. 2 and promotes cancer progression. Cancer Res., 66, 6649-6656.
32. Yang,L. et al. (2007) Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. Cancer Res., 67, 5587-5593.
33. Chi,X. et al. (2009) 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. Arch. Biochem. Biophys., 487, 139-145.
34. Xu,C. et al. (2005) Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest., 115, 2656-2664.
35. Tsujii,M. et al. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
36. 2 promotes angiogenesis in colorectal cancer. J. Exp. Med., 203, 941-951.
37. Thun,M.J. et al. (1993) Aspirin use and risk of fatal cancer. Cancer Res., 53, 1322-1327.
38. Yan,M. et al. (2009) 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc. Natl Acad. Sci., 106, 9409-9413.
39. Backlund,M.G. et al. (2005) 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J. Biol. Chem., 280, 3217-3223.
40. Yan,M. et al. (2004) 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc. Natl Acad. Sci. USA, 101, 17468-17473.
41. Hennessy,B.T. et al. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov., 4, 988-1004.
42. Ma,Y. et al. (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat. Rev. Cancer, 4, 966-977.
43. Zhang,B. et al. (2010) ER stress induced by ionising radiation in IEC-6 cells. Int. J. Radiat. Biol., 86, 429-435.
44. Tsutsumi,S. et al. (2004) Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis. Cell Death Differ., 11, 1009-1016.
45. Kardosh,A. et al. (2008) Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res., 68, 843-851.
46. Obeng,E.A. et al. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood, 107, 4907-4916.
47. Rigas,B. et al. (1993) Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122, 518-523.
48. 2 in human colon cancer cells. Cancer Res., 58, 362-366.